| The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma American Journal of Surgical Pathology 29 (9), 1228-1242, 2005 | 6082* | 2005 |
| Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study JW Yaxley, GD Coughlin, SK Chambers, S Occhipinti, H Samaratunga, ... The Lancet 388 (10049), 1057-1066, 2016 | 720 | 2016 |
| Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study P Ström, K Kartasalo, H Olsson, L Solorzano, B Delahunt, DM Berney, ... The Lancet Oncology 21 (2), 222-232, 2020 | 455 | 2020 |
| Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study GD Coughlin, JW Yaxley, SK Chambers, S Occhipinti, H Samaratunga, ... The Lancet Oncology 19 (8), 1051-1060, 2018 | 435 | 2018 |
| The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma GJLH Van Leenders, TH Van Der Kwast, DJ Grignon, AJ Evans, ... The American journal of surgical pathology 44 (8), e87-e99, 2020 | 379 | 2020 |
| International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. Working group 1: specimen handling H Samaratunga, R Montironi, L True, JI Epstein, DF Griffiths, ... Modern Pathology 24 (1), 6-15, 2011 | 295 | 2011 |
| Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge W Bulten, K Kartasalo, PHC Chen, P Ström, H Pinckaers, K Nagpal, Y Cai, ... Nature medicine 28 (1), 154-163, 2022 | 256 | 2022 |
| International Society of Urological Pathology (ISUP) grading of prostate cancer–An ISUP consensus on contemporary grading L Egevad, B Delahunt, JR Srigley, H Samaratunga Apmis 124 (6), 433-435, 2016 | 215 | 2016 |
| Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study H Samaratunga, K Khoo Histopathology 45 (1), 55-64, 2004 | 207 | 2004 |
| Grading of renal cell carcinoma B Delahunt, JN Eble, L Egevad, H Samaratunga Histopathology 74 (1), 4-17, 2019 | 178 | 2019 |
| Use of multiple biomarkers for a molecular diagnosis of prostate cancer KA Landers, MJ Burger, MA Tebay, DM Purdie, B Scells, H Samaratunga, ... International journal of cancer 114 (6), 950-956, 2005 | 177 | 2005 |
| Localization of N-Acetyltransferases NAT1 and NAT2 in Human Tissues KF Windmill, A Gaedigk, P de la M. Hall, H Samaratunga, DM Grant, ... Toxicological Sciences 54 (1), 19-29, 2000 | 171 | 2000 |
| Expression analysis of δ‐catenin and prostate‐specific membrane antigen: Their potential as diagnostic markers for prostate cancer MJ Burger, MA Tebay, PA Keith, HM Samaratunga, J Clements, MF Lavin, ... International journal of cancer 100 (2), 228-237, 2002 | 170 | 2002 |
| Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker AAI Sina, LG Carrascosa, Z Liang, YS Grewal, A Wardiana, MJA Shiddiky, ... Nature communications 9 (1), 4915, 2018 | 166 | 2018 |
| Gleason grading: past, present and future B Delahunt, RJ Miller, JR Srigley, AJ Evans, H Samaratunga Histopathology 60 (1), 75-86, 2012 | 166 | 2012 |
| Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression H Samaratunga, DV Makarov, JI Epstein Urology 60 (2), 315-319, 2002 | 166 | 2002 |
| Human Kallikrein 4 (KLK4) Is Highly Expressed in Serous Ovarian Carcinomas Y Dong, A Kaushal, L Bui, S Chu, PJ Fuller, J Nicklin, H Samaratunga, ... Clinical cancer research 7 (8), 2363-2371, 2001 | 166 | 2001 |
| Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs): KLK4 and PAR-2 are co-expressed during prostate cancer progression AJ Ramsay, Y Dong, ML Hunt, ML Linn, H Samaratunga, JA Clements, ... Journal of Biological Chemistry 283 (18), 12293-12304, 2008 | 165 | 2008 |
| The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with … MB Amin, DW Lin, JL Gore, JR Srigley, H Samaratunga, L Egevad, ... Archives of Pathology and Laboratory Medicine 138 (10), 1387-1405, 2014 | 158 | 2014 |
| A working group classification of focal prostate atrophy lesions AM De Marzo, EA Platz, JI Epstein, T Ali, A Billis, TY Chan, L Cheng, ... The American journal of surgical pathology 30 (10), 1281-1291, 2006 | 158 | 2006 |
Brett DelahuntПодтвержден адрес электронной почты в домене otago.ac.nz
